The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo

被引:22
|
作者
Huang, Chixiong [1 ]
Huang, Senlin
Li, Hairui [1 ]
Li, Xinzhong [1 ]
Li, Bing [1 ]
Zhong, Lintao [1 ]
Wang, Junfeng [2 ]
Zou, Meishen [1 ]
He, Xiang [1 ]
Zheng, Hao [1 ]
Si, Xiaoyun [1 ]
Liao, Wangjun [3 ]
Liao, Yulin [1 ]
Yang, Li [4 ]
Bin, Jianping [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, 1838 Guangzhou Ave North, Guangzhou 510515, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Ultrasound; Multidrug resistance; P-glycoprotein; Reactive oxygen species; HUMAN BREAST-CANCER; OXIDATIVE STRESS; GENE-EXPRESSION; DOWN-REGULATION; CELLS; MIR-34A; MICRORNAS; ZEB1; MECHANISMS; APOPTOSIS;
D O I
10.1186/s13046-018-0900-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Multidrug resistance (MDR) is often responsible for the failure of chemotherapy treatment, and current strategies for cancer MDR are not adequately satisfying as to their efficacy and safety. In this study, we sought to determine the anti-MDR effects of ultrasound (US) irradiation and its underlying mechanisms against drug-resistance. Methods: MDR variant MCF-7/ADR cell lines and endothelial cell lines were used to determine the appropriate ultrasound intensity for in vitro experiments. MCF-7/ADR cell and HEPG2/ADM cells were used to assess the anti-MDR effect of US irradiation. Intracellular adriamycin (ADM) accumulation, Cell viability, cell proliferation and cell apoptosis were evaluated after ADM + US treatment or ADM treatment alone. MCF-7/ADR xenograft mice were used to investigate the appropriate ultrasound intensity for in vivo experiments and its effect on the long-term prognosis. Underlining mechanisms by which ultrasound exposure reversing MDR phenotype were investigated both in vitro and in vivo. Results: Combination of ADM and 0.74 W/cm(2) US irradiation enhanced ADM intracellular concentration and nuclear accumulation in MCF-7/ADR and HEPG2/ADM cells, compared to those treated with ADM alone. Enhanced cellular ADM uptake and nuclei localization was associated with increased cytotoxicity of ADM to ADM-resistant cells, lower ADM-resistant cell viability and proliferative cell ratio, and higher apoptotic cell ratio. More importantly, US exposure increased the effectiveness of ADM to inhibit tumor growth in MCF-7/ADR xenograft mice. Mechanistically, US exposure promoted ADM accumulation in MDR cells mainly through down-regulation of P-glycoprotein (P-gp), which is dependent on US-induced intracellular reactive oxygen species (ROS) production. US-induced oxidative stress promoted miR-200c-3p and miR-34a-3p expression by forming miR-200c/34a/ZEB1 double-negative feedback loop. Finally, US-induced miR-200c/34a overexpression decreased P-gp expression and reversed MDR phenotype. Conclusion: US irradiation could reverse MDR phenotype by activating ROS-ZEB1-miR200c/34a-P-gp signal pathway. Our findings offer a new and promising strategy for sensitizing cells to combat MDR and to improve the therapeutic index of chemotherapy.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo
    Chixiong Huang
    Senlin Huang
    Hairui Li
    Xinzhong Li
    Bing Li
    Lintao Zhong
    Junfeng Wang
    Meishen Zou
    Xiang He
    Hao Zheng
    Xiaoyun Si
    Wangjun Liao
    Yulin Liao
    Li Yang
    Jianping Bin
    Journal of Experimental & Clinical Cancer Research, 37
  • [2] In vivo model systems in P-glycoprotein-mediated multidrug resistance
    van de Vrie, W
    Marquet, RL
    Stoter, G
    De Bruijn, EA
    Eggermont, AMM
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1998, 35 (01) : 1 - 57
  • [3] Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo
    Qi, J
    Wang, SB
    Liu, GY
    Peng, H
    Wang, JH
    Zhu, ZP
    Yang, CZ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (04) : 1124 - 1131
  • [4] THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
    ENDICOTT, JA
    LING, V
    ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 : 137 - 171
  • [5] Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin
    Gao, Aili
    Wang, Xiangjing
    Xiang, Wensheng
    Liang, Hongsheng
    Gao, Jiguo
    Yan, Yijun
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (03) : 393 - 399
  • [6] Reversal of P-glycoprotein-mediated multidrug resistance in vitro by antihistamines and diuretics.
    Aszalos, A
    Ibrahim, S
    Knapton, A
    Licht, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 106 - 106
  • [7] In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576
    Mistry, P
    Stewart, AJ
    Dangerfield, W
    Okiji, S
    Liddle, C
    Bootle, D
    Plumb, JA
    Templeton, D
    Charlton, P
    CANCER RESEARCH, 2001, 61 (02) : 749 - 758
  • [8] DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo
    Shionoya, M
    Jimbo, T
    Kitagawa, M
    Soga, T
    Tohgo, A
    CANCER SCIENCE, 2003, 94 (05) : 459 - 466
  • [9] P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo
    Abe, Y
    Ohnishi, Y
    Yoshimura, M
    Ota, E
    Ozeki, Y
    Oshika, Y
    Tokunaga, T
    Yamazaki, H
    Ueyema, Y
    Ogata, T
    Tamaoki, N
    Nakamura, M
    BRITISH JOURNAL OF CANCER, 1996, 74 (12) : 1929 - 1934
  • [10] In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of Stealth™ RNAi
    Xiao, Hong
    Wu, Zhuo
    Shen, Hong
    Luo, Ai-Lan
    Yang, Yu-Fei
    Li, Xiao-Bo
    Zhu, Dong-Ya
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (04) : 342 - 348